NNNN Anbio Biotechnology

NAS · US · Healthcare · Medical Instruments & Supplies · anbiobiotechnology.com

4.900USD0.00%Mkt Cap: 215.07M $P/E: 32.671d ago

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immun…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$73.12BUSDP/E 27.4

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$23.14BUSDP/E 72.7

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.50BUSDP/E 73.0

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap215.07M USD

Enterprise Value203.17M USD

Revenue (TTM)8.65M USD

Gross Profit7.54M USD

Net Income (TTM)6.40M USD

Revenue/Share0.20 USD

Last Price4.900 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees27

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)32.67

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue23.50

P/S24.87

P/B7.13

EPS (TTM)0.15

EPS (Forward)—

52W Range

4.6601% of range44.73

52W High44.73 USD

52W Low4.660 USD

Profitability

Gross Margin87.24%

Oper. Margin59.09%

EBITDA Margin0.00%

Profit Margin74.06%

ROE21.24%

ROA21.17%

Growth

Revenue Growth73.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.74M USD

CapEx (TTM)—

FCF Margin-111.09%

FCF Yield-4.47%

Net Debt-11.90M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio344.31

Quick Ratio177.13

Book Value/Sh0.69 USD

Cash/Share0.27 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.43.89M

Float39.69M

Insiders4.78%

Institutions5.01%

Short Interest

Short Ratio0.2d

Short % Float0.12%

Short % Out.0.12%

Shares Short51.67K

Short (prev mo.)26.21K

Technical

SMA 507.686 (-36.2%)

SMA 20020.15 (-75.7%)

Beta—

S&P 52W Chg15.78%

Avg Vol (30d)204.59K

Avg Vol (10d)128.72K

Technical Indicators

RSI (14)29.8

MACD-0.6214

MACD Signal-0.6312

MACD Hist.+0.0097

BB Upper6.830 USD

BB Middle5.785 USD

BB Lower4.739 USD

BB Width36.15%

ATR (14)0.6492 USD

Vol Ratio (20d)0.19x